Collegium pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Collegium Pharmaceutical Inc: Is Infosys Ltd. worth buying?
Item: Collegium Pharmaceutical Inc
Rating: 2.758222375
Author: Trendlyne DVM scores

Strong Performer, Under Radar

about

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated pr...

34.83 -0.04 (-0.11%)

31.42% Fall from 52W High

287.3K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Collegium pharma Inc is on 15 May 2026 for the purpose of Collegium Pharmaceutical Inc Annual General Meeting for 2026 See details

High Financial Strength

55.6 / 100

Affordable Valuation

61.2 / 100

Technically Neutral

48.4 / 100

Strong Performer, Under Radar These stocks have good quality scores and strong financials. They are affordably priced stocks with potential for good returns View Similar Embed DVM

1Yr Price target upside is 56%

6 analysts

Collegium pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Collegium pharma Inc Live Stock Price Today, Share Analysis and Chart

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated pr...

31.42% Fall from 52W High

SWOT Analysis

Collegium pharma Inc Live Price Chart